Published in Biochemistry on March 03, 2009
Insights from the analysis of conserved motifs and permitted amino acid exchanges in the human, the fly and the worm GPCR clusters. Bioinformation (2011) 0.85
Light-induced photoreceptor and RPE degeneration involve zinc toxicity and are attenuated by pyruvate, nicotinamide, or cyclic light. Mol Vis (2010) 0.83
Allosteric Modulation of G Protein Coupled Receptors by Cytoplasmic, Transmembrane and Extracellular Ligands. Pharmaceuticals (Basel) (2010) 0.81
A reduced zinc diet or zinc transporter 3 knockout attenuate light induced zinc accumulation and retinal degeneration. Exp Eye Res (2012) 0.76
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis (1997) 57.27
Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60
The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol (2004) 7.38
The neurobiology of zinc in health and disease. Nat Rev Neurosci (2005) 5.07
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron (2001) 4.42
Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc Natl Acad Sci U S A (2002) 4.12
Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A (1991) 4.10
Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry (2001) 3.62
Release of endogenous Zn2+ from brain tissue during activity. Nature (1984) 3.59
GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res (2003) 3.34
Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron (1992) 3.25
Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. Proc Natl Acad Sci U S A (1988) 3.01
Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem (1998) 2.78
Stimulation-induced uptake and release of zinc in hippocampal slices. Nature (1984) 2.38
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron (2008) 2.30
Assembly of functional rhodopsin requires a disulfide bond between cysteine residues 110 and 187. J Biol Chem (1990) 2.18
Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr (2000) 2.16
Role of the intradiscal domain in rhodopsin assembly and function. Proc Natl Acad Sci U S A (1990) 1.97
Structure and function in rhodopsin: replacement by alanine of cysteine residues 110 and 187, components of a conserved disulfide bond in rhodopsin, affects the light-activated metarhodopsin II state. Proc Natl Acad Sci U S A (1994) 1.62
Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor. Biochemistry (2003) 1.40
Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry (2001) 1.26
Allosteric modulation of beta2-adrenergic receptor by Zn(2+). Mol Pharmacol (2002) 1.25
Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors. J Biol Chem (1997) 1.24
Stability of dark state rhodopsin is mediated by a conserved ion pair in intradiscal loop E-2. J Biol Chem (2003) 1.15
Structure and function in rhodopsin: Mass spectrometric identification of the abnormal intradiscal disulfide bond in misfolded retinitis pigmentosa mutants. Proc Natl Acad Sci U S A (2001) 1.15
Current status of metals as therapeutic targets in Alzheimer's disease. J Am Geriatr Soc (2003) 1.14
Is the olfactory receptor a metalloprotein? Proc Natl Acad Sci U S A (2003) 1.07
Insertional mutagenesis as a probe of rhodopsin's topography, stability, and activity. J Biol Chem (1994) 1.06
Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions. Exp Gerontol (2000) 1.05
Stabilizing effect of Zn2+ in native bovine rhodopsin. J Biol Chem (2007) 1.05
Structure and function in rhodopsin: further elucidation of the role of the intradiscal cysteines, Cys-110, -185, and -187, in rhodopsin folding and function. Proc Natl Acad Sci U S A (1999) 1.04
Critical role of transmembrane segment zinc binding in the structure and function of rhodopsin. J Biol Chem (2004) 1.03
Pharmacological strategies for the prevention of Alzheimer's disease. Expert Opin Pharmacother (2006) 1.02
Rhodopsin and retinitis pigmentosa: shedding light on structure and function. Receptors Channels (2002) 1.00
Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors. J Biol Chem (2002) 0.94
Molecular mechanism of agonism and inverse agonism in the melanocortin receptors: Zn(2+) as a structural and functional probe. Ann N Y Acad Sci (2003) 0.93
Metal-protein attenuating compounds and Alzheimer's disease. Expert Opin Investig Drugs (2004) 0.91
Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms. J Pharmacol Exp Ther (1999) 0.90
Identification of an allosteric binding site for Zn2+ on the beta2 adrenergic receptor. J Biol Chem (2002) 0.90
Zinc allosterically modulates antagonist binding to cloned D1 and D2 dopamine receptors. J Neurochem (1997) 0.89
Retinitis pigmentosa rhodopsin mutations L125R and A164V perturb critical interhelical interactions: new insights through compensatory mutations and crystal structure analysis. J Biol Chem (2003) 0.87
Identification of a Zn2+-binding site on the dopamine D2 receptor. Biochem Biophys Res Commun (2006) 0.85
Zinc-induced decrease of the thermal stability and regeneration of rhodopsin. J Biol Chem (2002) 0.83
Natural agonist enhancing bis-His zinc-site in transmembrane segment V of the tachykinin NK3 receptor. FEBS Lett (1998) 0.81
Differential subcellular localization of zinc in the rat retina. J Histochem Cytochem (2001) 0.80
Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity. Circulation (2013) 2.95
Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet (2013) 2.91
G protein Galphai functions immediately downstream of Smoothened in Hedgehog signalling. Nature (2008) 1.88
Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J Cell Biol (2005) 1.74
Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development. Circ Res (2013) 1.68
Light-driven activation of beta 2-adrenergic receptor signaling by a chimeric rhodopsin containing the beta 2-adrenergic receptor cytoplasmic loops. Biochemistry (2005) 1.48
IntraLase femtosecond laser vs mechanical microkeratomes in LASIK for myopia: a systematic review and meta-analysis. J Refract Surg (2012) 1.41
Opsin is a phospholipid flippase. Curr Biol (2011) 1.27
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition. Circ Res (2008) 1.17
The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway. Am J Physiol Heart Circ Physiol (2006) 1.12
Aldose reductase, oxidative stress, and diabetic mellitus. Front Pharmacol (2012) 1.10
A novel pathway for nickel-induced interleukin-8 expression. J Biol Chem (2002) 1.08
Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane. J Clin Invest (2011) 1.07
Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. Arterioscler Thromb Vasc Biol (2011) 1.05
NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies. PLoS One (2011) 1.04
Cardioprotective prostacyclin signaling in vascular smooth muscle. Prostaglandins Other Lipid Mediat (2006) 1.04
Critical role of transmembrane segment zinc binding in the structure and function of rhodopsin. J Biol Chem (2004) 1.03
Rhodopsin and retinitis pigmentosa: shedding light on structure and function. Receptors Channels (2002) 1.00
The critical role of transmembrane prolines in human prostacyclin receptor activation. Mol Pharmacol (2002) 0.99
The unique ligand-binding pocket for the human prostacyclin receptor. Site-directed mutagenesis and molecular modeling. J Biol Chem (2002) 0.97
Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype. J Mol Cell Cardiol (2011) 0.93
Tumor necrosis factor induces sodium retention in diabetic rats through sequential effects on distal tubule cells. Kidney Int (2004) 0.92
Arginine (CGC) codon targeting in the human prostacyclin receptor gene (PTGIR) and G-protein coupled receptors (GPCR). Gene (2007) 0.92
Impaired receptor binding and activation associated with a human prostacyclin receptor polymorphism. J Biol Chem (2002) 0.92
Site-directed mutations and the polymorphic variant Ala160Thr in the human thromboxane receptor uncover a structural role for transmembrane helix 4. PLoS One (2012) 0.92
Prostacyclin primes pregnant human myometrium for an enhanced contractile response in parturition. J Clin Invest (2008) 0.92
Human prostacyclin receptor structure and function from naturally-occurring and synthetic mutations. Prostaglandins Other Lipid Mediat (2006) 0.91
Clusters of transmembrane residues are critical for human prostacyclin receptor activation. Biochemistry (2004) 0.91
Versatility and differential roles of cysteine residues in human prostacyclin receptor structure and function. J Biol Chem (2006) 0.91
Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation (2014) 0.90
Knock-in mouse model of alternating hemiplegia of childhood: behavioral and electrophysiologic characterization. Epilepsia (2014) 0.89
Adenylyl cyclase type 6 overexpression selectively enhances beta-adrenergic and prostacyclin receptor-mediated inhibition of cardiac fibroblast function because of colocalization in lipid rafts. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.89
Seizure predisposition after perinatal hypoxia: effects of subsequent age and of an epilepsy predisposing gene mutation. Epilepsia (2013) 0.88
Retinitis pigmentosa rhodopsin mutations L125R and A164V perturb critical interhelical interactions: new insights through compensatory mutations and crystal structure analysis. J Biol Chem (2003) 0.87
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study. Pharmacogenet Genomics (2008) 0.87
Transepithelial, Topography-guided Ablation in the Treatment of Visual Disturbances in LASIK Flap or Interface Complications. J Refract Surg (2011) 0.86
Penetration of riboflavin and postoperative pain in corneal collagen crosslinking: excimer laser superficial versus mechanical full-thickness epithelial removal. J Cataract Refract Surg (2009) 0.86
Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease. Curr Atheroscler Rep (2009) 0.85
An eicosanoid-centric view of atherothrombotic risk factors. Cell Mol Life Sci (2012) 0.84
Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol (2010) 0.84
Meta-analysis of clinical outcomes comparing surface ablation for correction of myopia with and without 0.02% mitomycin C. J Refract Surg (2011) 0.83
New insights into structural determinants for prostanoid thromboxane A2 receptor- and prostacyclin receptor-G protein coupling. Mol Cell Biol (2012) 0.83
Hematopoietic stem cells expanded by fibroblast growth factor-1 are excellent targets for retrovirus-mediated gene delivery. Exp Hematol (2005) 0.82
Novel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation. J Mol Cell Cardiol (2009) 0.81
Light microscopy applications in systems biology: opportunities and challenges. Cell Commun Signal (2013) 0.80
Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif. J Lipid Res (2013) 0.80
Exploration of the antiplatelet activity profile of betulinic acid on human platelets. J Agric Food Chem (2012) 0.80
Prostacyclin: an inflammatory paradox. Front Pharmacol (2011) 0.79
Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agent. J Med Chem (2010) 0.79
Postoperative Changes in Corneal Epithelial and Stromal Thickness Profiles After Photorefractive Keratectomy in Treatment of Myopia. J Refract Surg (2015) 0.78
Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysis. PLoS One (2013) 0.78
Comprehensive biochemical analysis of rare prostacyclin receptor variants: study of association of signaling with coronary artery obstruction. J Biol Chem (2010) 0.78
Shp shape: FAKs about hypertrophy. Circ Res (2008) 0.78
The human prostacyclin receptor from structure function to disease. Prog Mol Biol Transl Sci (2009) 0.77
Leukaemia-associated Rho guanine nucleotide exchange factor (LARG) plays an agonist specific role in platelet function through RhoA activation. Thromb Haemost (2016) 0.77
Topography-guided transepithelial surface ablation in treatment of recurrent epithelial ingrowths. J Refract Surg (2010) 0.76
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial. Haematologica (2012) 0.75
Regulation of VWF expression, and secretion in health and disease. Curr Opin Hematol (2016) 0.75
Topography-Guided Transepithelial Surface Ablation in the Treatment of Moderate to High Astigmatism. J Refract Surg (2016) 0.75
Comparison of clinical outcomes between 'on-flap' and 'off-flap' epi-LASIK for myopia: a meta-analysis. Ophthalmologica (2011) 0.75
Medium- to Long-Term Results of Corneal Cross-Linking for Keratoconus Using Phototherapeutic Keratectomy for Epithelial Removal and Partial Stromal Ablation. J Refract Surg (2017) 0.75
Epithelial Thickness Profile Change After Combined Topography-Guided Transepithelial Photorefractive Keratectomy and Corneal Cross-linking in Treatment of Keratoconus. J Refract Surg (2016) 0.75
Effect of limbal marking prior to laser ablation on the magnitude of cyclotorsional error. J Refract Surg (2012) 0.75
Aspheric Micro-monovision LASIK in Correction of Presbyopia and Myopic Astigmatism: Early Clinical Outcomes in a Chinese Population. J Refract Surg (2016) 0.75
Molecular Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib - Single Centre Experience. Pril (Makedon Akad Nauk Umet Odd Med Nauki) (2015) 0.75